BioPharm International-01-01-2007

BioPharm International

Final Word: Regulatory Evolution

January 01, 2007

Columns and Departments

20

1

How much do regulatory agencies know about nanotechnology or microfluidics? Yesterday, the answer was probably, "not much." Tomorrow, it may be "a lot." The reason is that new technologies push the agencies to expand their expertise.

From the Editor: Aggregate Knowledge

January 01, 2007

Columns and Departments

20

1

Given the complexity involved in the causes, mechanisms, and kinetics of protein aggregation, industry leaders and academics should continue to share knowledge and experience in this area.

Street Talk: Biopharm Exchange-Traded Funds: Their Time has Come

January 01, 2007

Columns and Departments

20

1

On a recent plane ride from Phoenix to Philly, I was leafing through a copy of the San Francisco Business Journal. I was taken aback by a story on the emerging trend of biopharm exchange-traded funds (ETFs), and how much of an impact they're having on Wall Street and on investors.

Salary Survey: Is Your Paycheck as Robust as Your Proteins?

January 01, 2007

Features

20

1

The biotechnology industry is thriving, and hopefully you are too. BioPharm International's first salary and employee satisfaction survey presents a wealth of data that will allow you to compare many aspects of your job with those of your peers. The survey reports on demographics, education, work experience, salary and benefits, and attitudes toward current employment.